Pubblicazioni dell'Unità di Neurologia OB
Pubblicato il
03/11/2020
- Michelucci R, Valzania F, Passarelli D, Santangelo M, Rizzi R, Buzzi AM, Tempestini A, Tassinari CA.
Rapid-rate transcranial magnetic stimulation and hemispheric language dominance: usefulness and safety in epilepsy.
Neurology. 1994 Sep; 44(9):1697-700. doi: 10.1212/wnl.44.9.1697. PMID: 7936299.
- Virtaneva K, D'Amato E, Miao J, Koskiniemi M, Norio R, Avanzini G, Franceschetti S, Michelucci R, Tassinari CA, Omer S, Pennacchio LA, Myers RM, Dieguez-Lucena JL, Krahe R, de la Chapelle A, Lehesjoki AE.
Unstable minisatellite expansion causing recessively inherited myoclonus epilepsy, EPM1.
Nature Genetics. 1997 Apr;15(4):393-6. doi: 10.1038/ng0497-393. PMID: 9090386.
- Serratosa JM, Gómez-Garre P, Gallardo ME, Anta B, de Bernabé DB, Lindhout D, Augustijn PB, Tassinari CA, Malafosse RM, Topcu M, Grid D, Dravet C, Berkovic SF, de Córdoba SR.
A novel protein tyrosine phosphatase gene is mutated in progressive myoclonus epilepsy of the Lafora type (EPM2).
Hum Mol Genet. 1999 Feb;8(2):345-52. doi: 10.1093/hmg/8.2.345. PMID: 9931343.
- Michelucci R, Poza JJ, Sofia V, de Feo MR, Binelli S, Bisulli F, Scudellaro E, Simionati B, Zimbello R, D'Orsi G, Passarelli D, Avoni P, Avanzini G, Tinuper P, Biondi R, Valle G, Mautner VF, Stephani U, Tassinari CA, Moschonas NK, Siebert R, Lopez de Munain A, Perez-Tur J, Nobile C.
Autosomal dominant lateral temporal epilepsy: clinical spectrum, new epitempin mutations, and genetic heterogeneity in seven European families.
Epilepsia. 2003 Oct;44(10):1289-97. doi: 10.1046/j.1528-1157.2003.20003.x. PMID: 14510822.
- Michelucci R, Mecarelli O, Bovo G, Bisulli F, Testoni S, Striano P, Striano S, Tinuper P, Nobile C.
A de novo LGI1 mutation causing idiopathic partial epilepsy with telephone-induced seizures.
Neurology. 2007 Jun 12;68(24):2150-1. doi: 10.1212/01.wnl.0000264932.44153.3c. PMID: 17562837.
- Dibbens LM, Michelucci R, Gambardella A, Andermann F, Rubboli G, Bayly MA, Joensuu T, Vears DF, Franceschetti S, Canafoglia L, Wallace R, Bassuk AG, Power DA, Tassinari CA, Andermann E, Lehesjoki AE, Berkovic SF.
SCARB2 mutations in progressive myoclonus epilepsy (PME) without renal failure.
Annals of Neurology. 2009 Oct; 66(4):532-6. doi: 10.1002/ana.21765. PMID: 19847901.
- Michelucci R, Pasini E, Malacrida S, Striano P, Bonaventura CD, Pulitano P, Bisulli F, Egeo G, Santulli L, Sofia V, Gambardella A, Elia M, de Falco A, Neve Al, Banfi P, Coppola G, Avoni P, Binelli S, Boniver C, Pisano T, Marchini M, Dazzo E, Fanciulli M, Bartolini Y, Riguzzi P, Volpi L, de Falco FA, Giallonardo AT, Mecarelli O, Striano S, Tinuper P, Nobile C.
Low penetrance of autosomal dominant lateral temporal epilepsy in Italian families without LGI1 mutations.
Epilepsia. 2013 Jul;54(7):1288-97. doi: 10.1111/epi.12194. Epub 2013 Apr 26. PMID: 23621105.
- Muona M, Berkovic SF, Dibbens LM, Oliver KL, Maljevic S, Bayly MA, Joensuu T, Canafoglia L, Franceschetti S, Michelucci R, Markkinen S, Heron SE, Hildebrand MS, Andermann E, Andermann F, Gambardella A, Tinuper P, Licchetta L, Scheffer IE, Criscuolo C, Filla A, Ferlazzo E, Ahmad J, Ahmad A, Baykan B, Said E, Topcu M, Riguzzi P, King MD, Ozkara C, Andrade DM, Engelsen BA, Crespel A, Lindenau M, Lohmann E, Saletti V, Massano J, Privitera M, Espay AJ, Kauffmann B, Duchowny M, Møller RS, Straussberg R, Afawi Z, Ben-Zeev B, Samocha KE, Daly MJ, Petrou S, Lerche H, Palotie A, Lehesjoki AE.
A recurrent de novo mutation in KCNC1 causes progressive myoclonus epilepsy.
Nature Genetics. 2015 Jan;47(1):39-46. doi: 10.1038/ng.3144. Epub 2014 Nov 17. PMID: 25401298; PMCID: PMC4281260. - Dazzo E, Rehberg K, Michelucci R, Passarelli D, Boniver C, Vianello Dri V, Striano P, Striano S, Pasterkamp RJ, Nobile C.
Mutations in MICAL-1cause autosomal-dominant lateral temporal epilepsy.
Annals of Neurology. 2018 Mar;83(3):483-493. doi: 10.1002/ana.25167. Epub 2018 Mar 13. PMID: 29394500.
- Mula M, Zaccara G, Galimberti CA, Ferrò B, Canevini MP, Mascia A, Mecarelli O, Michelucci R, Pisani LR, Specchio LM, Striano S, Perucca E.
Validated outcome of treatment changes according to International League Against Epilepsy criteria in adults with drug-resistant focal epilepsy.
Epilepsia. 2019 Jun;60(6):1114-1123. doi: 10.1111/epi.14685. Epub 2019 Mar 13. PMID: 30866058;